Search

A recent study conducted by researchers at Baylor University College of Medicine in Houston, Texas, has revealed new insights into the role of MYC in breast cancer. The study found that MYC induces a type of oncogenic stress by increasing global RNA degradation and ribonucleotide catabolism, leading to the accumulation of cytotoxic RNA catabolites and reactive oxygen species. The researchers suggest that targeting this catabolic vulnerability could be a potential therapeutic approach for MYC-driven cancers. The study was funded by various organizations, including the Susan G. Komen Breast Cancer Foundation and the National Institutes of Health. [Extracted from the article]